![Craig S. Lewis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Craig S. Lewis
Präsident bei Ironshore Pharmaceuticals (America), Inc.
Profil
Mr. Craig S.
Lewis is Chief Marketing & Senior Vice President at AssureRx Health, Inc. He is on the Board of Directors at Ironshore Pharmaceuticals (America), Inc. He received his undergraduate degree from the University of Cincinnati (Ohio) and an MBA from Xavier University.
Aktive Positionen von Craig S. Lewis
Unternehmen | Position | Beginn |
---|---|---|
Ironshore Pharmaceuticals (America), Inc.
![]() Ironshore Pharmaceuticals (America), Inc. Pharmaceuticals: MajorHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceuticals (America), Inc. manufactures pharmaceutical products. | Präsident | 12.05.2016 |
Ehemalige bekannte Positionen von Craig S. Lewis
Unternehmen | Position | Ende |
---|---|---|
Ironshore Therapeutics, Inc.
![]() Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Präsident | - |
Assurex Health, Inc.
![]() Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Corporate Officer/Principal | - |
Ausbildung von Craig S. Lewis
University of Cincinnati (Ohio) | Undergraduate Degree |
Xavier University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Assurex Health, Inc.
![]() Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Health Technology |
Ironshore Pharmaceuticals (America), Inc.
![]() Ironshore Pharmaceuticals (America), Inc. Pharmaceuticals: MajorHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceuticals (America), Inc. manufactures pharmaceutical products. | Health Technology |
Ironshore Therapeutics, Inc.
![]() Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Health Technology |